By disrupting the sialoglycan-Siglec pathway between tumor cells and T cells, Stanczak et al. demonstrated a delay of tumor growth and an increased infiltration of CD8+ T cells in a mouse model of colorectal cancer (35). The gene discussed is CD8A; the disease is neoplasm.